The global Genetically Engineered Vaccines for Poultry market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Genetically Engineered Vaccines for Poultry is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Genetically Engineered Vaccines for Poultry is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Genetically Engineered Vaccines for Poultry include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer Ingelheim, Indian Immunologicals, China Animal Husbandry Industry Co.,Ltd. and Yebio Bioengineering Co., Ltd Of Qingdao, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genetically Engineered Vaccines for Poultry, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetically Engineered Vaccines for Poultry.
Report Scope
The Genetically Engineered Vaccines for Poultry market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetically Engineered Vaccines for Poultry market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetically Engineered Vaccines for Poultry manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Sant茅 Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Segment by Type
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine
Segment by Application
Chickens
Duck
Goose
Pigeon
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genetically Engineered Vaccines for Poultry manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genetically Engineered Vaccines for Poultry in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Genetically Engineered Vaccines for Poultry 麻豆原创 Overview
1.1 Product Overview and Scope of Genetically Engineered Vaccines for Poultry
1.2 Genetically Engineered Vaccines for Poultry Segment by Type
1.2.1 Global Genetically Engineered Vaccines for Poultry 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Genetic Recombinant Vaccine
1.2.3 Recombinant Subunit Vaccines
1.2.4 Genetic Vaccine
1.3 Genetically Engineered Vaccines for Poultry Segment by Application
1.3.1 Global Genetically Engineered Vaccines for Poultry 麻豆原创 Value by Application: (2024-2030)
1.3.2 Chickens
1.3.3 Duck
1.3.4 Goose
1.3.5 Pigeon
1.3.6 Other
1.4 Global Genetically Engineered Vaccines for Poultry 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Genetically Engineered Vaccines for Poultry Revenue 2019-2030
1.4.2 Global Genetically Engineered Vaccines for Poultry Sales 2019-2030
1.4.3 Global Genetically Engineered Vaccines for Poultry 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Genetically Engineered Vaccines for Poultry 麻豆原创 Competition by Manufacturers
2.1 Global Genetically Engineered Vaccines for Poultry Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Genetically Engineered Vaccines for Poultry Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Genetically Engineered Vaccines for Poultry Average Price by Manufacturers (2019-2024)
2.4 Global Genetically Engineered Vaccines for Poultry Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genetically Engineered Vaccines for Poultry, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetically Engineered Vaccines for Poultry, Product Type & Application
2.7 Genetically Engineered Vaccines for Poultry 麻豆原创 Competitive Situation and Trends
2.7.1 Genetically Engineered Vaccines for Poultry 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genetically Engineered Vaccines for Poultry Players 麻豆原创 Share by Revenue
2.7.3 Global Genetically Engineered Vaccines for Poultry 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genetically Engineered Vaccines for Poultry Retrospective 麻豆原创 Scenario by Region
3.1 Global Genetically Engineered Vaccines for Poultry 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Genetically Engineered Vaccines for Poultry Global Genetically Engineered Vaccines for Poultry Sales by Region: 2019-2030
3.2.1 Global Genetically Engineered Vaccines for Poultry Sales by Region: 2019-2024
3.2.2 Global Genetically Engineered Vaccines for Poultry Sales by Region: 2025-2030
3.3 Global Genetically Engineered Vaccines for Poultry Global Genetically Engineered Vaccines for Poultry Revenue by Region: 2019-2030
3.3.1 Global Genetically Engineered Vaccines for Poultry Revenue by Region: 2019-2024
3.3.2 Global Genetically Engineered Vaccines for Poultry Revenue by Region: 2025-2030
3.4 North America Genetically Engineered Vaccines for Poultry 麻豆原创 Facts & Figures by Country
3.4.1 North America Genetically Engineered Vaccines for Poultry 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Genetically Engineered Vaccines for Poultry Sales by Country (2019-2030)
3.4.3 North America Genetically Engineered Vaccines for Poultry Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Genetically Engineered Vaccines for Poultry 麻豆原创 Facts & Figures by Country
3.5.1 Europe Genetically Engineered Vaccines for Poultry 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Genetically Engineered Vaccines for Poultry Sales by Country (2019-2030)
3.5.3 Europe Genetically Engineered Vaccines for Poultry Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetically Engineered Vaccines for Poultry 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Genetically Engineered Vaccines for Poultry 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Genetically Engineered Vaccines for Poultry Sales by Country (2019-2030)
3.6.3 Asia Pacific Genetically Engineered Vaccines for Poultry Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Genetically Engineered Vaccines for Poultry 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Genetically Engineered Vaccines for Poultry 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Genetically Engineered Vaccines for Poultry Sales by Country (2019-2030)
3.7.3 Latin America Genetically Engineered Vaccines for Poultry Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetically Engineered Vaccines for Poultry 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Genetically Engineered Vaccines for Poultry 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Genetically Engineered Vaccines for Poultry Sales by Country (2019-2030)
3.8.3 Middle East and Africa Genetically Engineered Vaccines for Poultry Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genetically Engineered Vaccines for Poultry Sales by Type (2019-2030)
4.1.1 Global Genetically Engineered Vaccines for Poultry Sales by Type (2019-2024)
4.1.2 Global Genetically Engineered Vaccines for Poultry Sales by Type (2025-2030)
4.1.3 Global Genetically Engineered Vaccines for Poultry Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Genetically Engineered Vaccines for Poultry Revenue by Type (2019-2030)
4.2.1 Global Genetically Engineered Vaccines for Poultry Revenue by Type (2019-2024)
4.2.2 Global Genetically Engineered Vaccines for Poultry Revenue by Type (2025-2030)
4.2.3 Global Genetically Engineered Vaccines for Poultry Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Genetically Engineered Vaccines for Poultry Price by Type (2019-2030)
5 Segment by Application
5.1 Global Genetically Engineered Vaccines for Poultry Sales by Application (2019-2030)
5.1.1 Global Genetically Engineered Vaccines for Poultry Sales by Application (2019-2024)
5.1.2 Global Genetically Engineered Vaccines for Poultry Sales by Application (2025-2030)
5.1.3 Global Genetically Engineered Vaccines for Poultry Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Genetically Engineered Vaccines for Poultry Revenue by Application (2019-2030)
5.2.1 Global Genetically Engineered Vaccines for Poultry Revenue by Application (2019-2024)
5.2.2 Global Genetically Engineered Vaccines for Poultry Revenue by Application (2025-2030)
5.2.3 Global Genetically Engineered Vaccines for Poultry Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Genetically Engineered Vaccines for Poultry Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Genetically Engineered Vaccines for Poultry Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Genetically Engineered Vaccines for Poultry Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Genetically Engineered Vaccines for Poultry Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoties Genetically Engineered Vaccines for Poultry Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elanco Genetically Engineered Vaccines for Poultry Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Genetically Engineered Vaccines for Poultry Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Indian Immunologicals Genetically Engineered Vaccines for Poultry Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 China Animal Husbandry Industry Co.,Ltd.
6.8.1 China Animal Husbandry Industry Co.,Ltd. Corporation Information
6.8.2 China Animal Husbandry Industry Co.,Ltd. Description and Business Overview
6.8.3 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.8.4 China Animal Husbandry Industry Co.,Ltd. Genetically Engineered Vaccines for Poultry Product Portfolio
6.8.5 China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
6.9 Yebio Bioengineering Co., Ltd Of Qingdao
6.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Corporation Information
6.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Description and Business Overview
6.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Genetically Engineered Vaccines for Poultry Product Portfolio
6.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
6.10 Jinyu Bio-technology Co.,ltd.
6.10.1 Jinyu Bio-technology Co.,ltd. Corporation Information
6.10.2 Jinyu Bio-technology Co.,ltd. Description and Business Overview
6.10.3 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jinyu Bio-technology Co.,ltd. Genetically Engineered Vaccines for Poultry Product Portfolio
6.10.5 Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
6.11 HVRI
6.11.1 HVRI Corporation Information
6.11.2 HVRI Genetically Engineered Vaccines for Poultry Description and Business Overview
6.11.3 HVRI Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.11.4 HVRI Genetically Engineered Vaccines for Poultry Product Portfolio
6.11.5 HVRI Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Genetically Engineered Vaccines for Poultry Description and Business Overview
6.12.3 Ringpu Biology Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ringpu Biology Genetically Engineered Vaccines for Poultry Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 Kyoto Biken Laboratories
6.13.1 Kyoto Biken Laboratories Corporation Information
6.13.2 Kyoto Biken Laboratories Genetically Engineered Vaccines for Poultry Description and Business Overview
6.13.3 Kyoto Biken Laboratories Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Kyoto Biken Laboratories Genetically Engineered Vaccines for Poultry Product Portfolio
6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Corporation Information
6.14.2 FATRO Genetically Engineered Vaccines for Poultry Description and Business Overview
6.14.3 FATRO Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.14.4 FATRO Genetically Engineered Vaccines for Poultry Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 Ceva Sant茅 Animale
6.15.1 Ceva Sant茅 Animale Corporation Information
6.15.2 Ceva Sant茅 Animale Genetically Engineered Vaccines for Poultry Description and Business Overview
6.15.3 Ceva Sant茅 Animale Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Ceva Sant茅 Animale Genetically Engineered Vaccines for Poultry Product Portfolio
6.15.5 Ceva Sant茅 Animale Recent Developments/Updates
6.16 Pulike Biological Engineering,Inc.
6.16.1 Pulike Biological Engineering,Inc. Corporation Information
6.16.2 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Poultry Description and Business Overview
6.16.3 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Pulike Biological Engineering,Inc. Genetically Engineered Vaccines for Poultry Product Portfolio
6.16.5 Pulike Biological Engineering,Inc. Recent Developments/Updates
6.17 Wuhan Hvsen Biotechnology CO.,LTD
6.17.1 Wuhan Hvsen Biotechnology CO.,LTD Corporation Information
6.17.2 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Poultry Description and Business Overview
6.17.3 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Wuhan Hvsen Biotechnology CO.,LTD Genetically Engineered Vaccines for Poultry Product Portfolio
6.17.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
6.18 Jinhe Biotechnology Co., Ltd.
6.18.1 Jinhe Biotechnology Co., Ltd. Corporation Information
6.18.2 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Poultry Description and Business Overview
6.18.3 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Poultry Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Jinhe Biotechnology Co., Ltd. Genetically Engineered Vaccines for Poultry Product Portfolio
6.18.5 Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetically Engineered Vaccines for Poultry Industry Chain Analysis
7.2 Genetically Engineered Vaccines for Poultry Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetically Engineered Vaccines for Poultry Production Mode & Process
7.4 Genetically Engineered Vaccines for Poultry Sales and 麻豆原创ing
7.4.1 Genetically Engineered Vaccines for Poultry Sales Channels
7.4.2 Genetically Engineered Vaccines for Poultry Distributors
7.5 Genetically Engineered Vaccines for Poultry Customers
8 Genetically Engineered Vaccines for Poultry 麻豆原创 Dynamics
8.1 Genetically Engineered Vaccines for Poultry Industry Trends
8.2 Genetically Engineered Vaccines for Poultry 麻豆原创 Drivers
8.3 Genetically Engineered Vaccines for Poultry 麻豆原创 Challenges
8.4 Genetically Engineered Vaccines for Poultry 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Sant茅 Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
听
听
*If Applicable.